Rory Bowden, Robert W. Davies, Andreas Heger, Alistair T. Pagnamenta, Mariateresa de Cesare, Laura E. Oikkonen, Duncan Parkes, Colin Freema, Fatima Dhalla, Smita Y. Patel, Niko Popitsch, Camilla L.C. Ip, Hannah E. Roberts, Silvia Salatino, Helen Lockstone, Gerton Lunter, Jenny C. Taylor, David Buck, Michael A. Simpson, Peter Donnelly
The potential of using Oxford Nanopore Technologies MinION sequencer is evaluated for Whole Genome Sequencing (WGS). A reference sample (NA112878) was sequenced alongside an individual with clinical indications. The authors applied novel bioinformatic approaches to the analysis and identify innovations that could significantly improve the platform’s potential for clinical WGS.
BluePippin was used to enrich DNA fragments >6kb using the High-Pass protocol prior to library construction.
Wellcome Centre for Human Genetics, Oxford UK
Hospital for Sick Children, Toronto CA
Oxford University, Oxford UK
National Institute for Health Research, Oxford UK
Children’s Cancer Research Institute, Vienna Austria